MattBloodMD

Extended-dose DOAC vs full-dose DOAC #Renove trial #ASH24 Late breaking abstract. Officially, reduced dose was not non-inferior, but recurrent #VTE rates were low and there is a substantial reduction in major and non-major bleeding. Congratulations to the French colleagues of #Innovte!

10.12.2024 16:27 — 👍 16    🔁 2    💬 0    📌 0

We humbly thank the reviewers for their suggestions. We would like to resubmit this improved manuscript for your consideration. #AcademicSky #MedSky

29.11.2024 16:25 — 👍 126    🔁 21    💬 9    📌 2

No apparent association between mRNA COVID-19 vaccination and venous thromboembolism By January 2022 over ten billion doses of COVID-19 vaccines had been administered worldwide. Concerns about COVID-19 vaccine-associated thrombosis aro…

No Apparent Association Between mRNA vaccines and venous thromboembolism
www.sciencedirect.com/science/arti...

29.11.2024 23:04 — 👍 7    🔁 1    💬 0    📌 0

We humbly thank the reviewers for their suggestions. We would like to resubmit this improved manuscript for your consideration. #AcademicSky #MedSky

29.11.2024 16:25 — 👍 126    🔁 21    💬 9    📌 2

Paper: Extended Treatment of Venous Thromboembolism with Reduced- Vs Full-Dose Direct Oral Anticoagulants in Patients at High Risk of Recurrence

🎉Congratulations Francis and the 🇫🇷 INNOVTE team for the RENOVE study that will be presented at ASH 2024 @ash-hematology.bsky.social as a Late-Breaking Abstract !
💊Reduced- Vs Full dose of DOAC for long terme anticoagulation after VTE ⤵️
ash.confex.com/ash/2024/web...

27.11.2024 15:32 — 👍 9    🔁 3    💬 0    📌 0